Back

Joining the Fight to Cure Neurodegenerative Disease

Lou Gehrig announcing he would leave baseball after having been diagnosed with amyotrophic lateral sclerosis (ALS)

(Download Image)

The Laboratory’s cutting-edge capabilities and expertise offer new tools to study ALS disease mechanisms and fuel hope for a cure.

Oct. 1, 2022

Featured Articles

LLNL researchers quantify metal strength uncertainty in high-explosives models

LLNL supports CO2 storage in California’s delta

Identifying material properties for more efficient solid-state batteries

Lawrence Livermore National Laboratory

| 7000 East Avenue • Livermore, CA 94550 | LLNL-WEB-735747

Operated by the Lawrence Livermore National Security, LLC for the Department of Energy's National Nuclear Security Administration Learn about the Department of Energy's Vulnerability Disclosure Program

Joining the Fight to Cure Neurodegenerative Disease

Tags

Featured Articles